A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors (Q33404760)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors |
scientific article |
Statements
1 reference
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors (English)
1 reference
Michael S Gordon
1 reference
Robert Ilaria
1 reference
Dinesh P de Alwis
1 reference
David S Mendelson
1 reference
Scott McKane
1 reference
Margaret M Wagner
1 reference
Katherine Y Look
1 reference
Patricia M LoRusso
1 reference
11 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference